The Patent Finder

Agouron Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Agouron Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Agouron Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,858,643Enantiomerically Pure Aminoheteroaryl Compounds as Protein Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,268,126Polymorphic and Amorphous Forms of the Phosphate Salt of 8-Fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-one
Term ended
Term ended Sep 21, 2025 · High confidence
Term endedTerm ended Sep 21, 2025High confidence
US 7,323,562Method of Preparing Poly(ADP-RIBOSE) Polymerases Inhibitors
Term ended
Term ended Sep 21, 2025 · High confidence
Term endedTerm ended Sep 21, 2025High confidence
US 6,534,524Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
Term ended
Term ended Apr 29, 2025 · USPTO record
Term endedTerm ended Apr 29, 2025USPTO record
US 8,785,632Enantiomerically Pure Aminoheteroaryl Compounds as Protein Kinase Inhibitors
Formerly held
Term ended
Term ended Mar 1, 2025 · Low confidence
Term endedTerm ended Mar 1, 2025Low confidence
US 6,495,541Tricyclic inhibitors of poly(ADP-ribose) polymerases
Formerly held
Term ended
Term ended Nov 22, 2023 · USPTO record
Term endedTerm ended Nov 22, 2023USPTO record
US 7,109,228Pyrazole derivatives
Term ended
Term ended Apr 20, 2023 · USPTO record
Term endedTerm ended Apr 20, 2023USPTO record
US 7,928,214P-cadherin antibodies
Lapsed on the fee record
Ended Apr 19, 2023 · USPTO record
Lapsed on the fee recordEnded Apr 19, 2023USPTO record
US 6,855,724Tropane Derivatives Useful in Therapy
Held by another company
Term ended
Term ended Apr 7, 2023 · High confidence
Term endedTerm ended Apr 7, 2023High confidence
US 7,125,905Pyrrole Substituted 2-Indolinone Protein Kinase Inhibitors
No holder on record
Term ended
Term ended Feb 15, 2021 · Low confidence
Term endedTerm ended Feb 15, 2021Low confidence
10 of 199 patents shown.
Pro members see all 199.
Pro members: see all 199 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited